nodes	percent_of_prediction	percent_of_DWPC	metapath
Frovatriptan—migraine—Prednisone—chronic obstructive pulmonary disease	0.49	1	CpDpCtD
Frovatriptan—CYP1A2—chronic obstructive pulmonary disease	0.378	1	CbGaD
Frovatriptan—CYP1A2—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00089	0.0777	CbGpPWpGaD
Frovatriptan—HTR1D—Serotonin receptors—HTR2A—chronic obstructive pulmonary disease	0.000503	0.0439	CbGpPWpGaD
Frovatriptan—HTR1B—Serotonin receptors—HTR2A—chronic obstructive pulmonary disease	0.000493	0.043	CbGpPWpGaD
Frovatriptan—HTR1A—Serotonin receptors—HTR2A—chronic obstructive pulmonary disease	0.000375	0.0328	CbGpPWpGaD
Frovatriptan—HTR1D—Monoamine GPCRs—ADRB2—chronic obstructive pulmonary disease	0.000286	0.025	CbGpPWpGaD
Frovatriptan—CYP1A2—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000283	0.0247	CbGpPWpGaD
Frovatriptan—HTR1B—Monoamine GPCRs—ADRB2—chronic obstructive pulmonary disease	0.000281	0.0245	CbGpPWpGaD
Frovatriptan—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.000241	0.0211	CbGpPWpGaD
Frovatriptan—HTR1D—Amine ligand-binding receptors—ADRB2—chronic obstructive pulmonary disease	0.000241	0.021	CbGpPWpGaD
Frovatriptan—HTR1B—Amine ligand-binding receptors—ADRB2—chronic obstructive pulmonary disease	0.000236	0.0206	CbGpPWpGaD
Frovatriptan—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000226	0.00187	CcSEcCtD
Frovatriptan—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000226	0.00187	CcSEcCtD
Frovatriptan—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000225	0.00186	CcSEcCtD
Frovatriptan—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.000224	0.00186	CcSEcCtD
Frovatriptan—HTR1D—Monoamine GPCRs—HTR2A—chronic obstructive pulmonary disease	0.000224	0.0196	CbGpPWpGaD
Frovatriptan—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.000224	0.00185	CcSEcCtD
Frovatriptan—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.000224	0.00185	CcSEcCtD
Frovatriptan—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000223	0.00185	CcSEcCtD
Frovatriptan—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.000223	0.00185	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000222	0.00184	CcSEcCtD
Frovatriptan—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000221	0.00184	CcSEcCtD
Frovatriptan—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000221	0.00184	CcSEcCtD
Frovatriptan—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000221	0.00183	CcSEcCtD
Frovatriptan—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000221	0.00183	CcSEcCtD
Frovatriptan—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.00022	0.00183	CcSEcCtD
Frovatriptan—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.00022	0.00182	CcSEcCtD
Frovatriptan—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.00022	0.0192	CbGpPWpGaD
Frovatriptan—HTR1B—Monoamine GPCRs—HTR2A—chronic obstructive pulmonary disease	0.000219	0.0191	CbGpPWpGaD
Frovatriptan—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000219	0.00181	CcSEcCtD
Frovatriptan—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000219	0.00181	CcSEcCtD
Frovatriptan—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.000217	0.0018	CcSEcCtD
Frovatriptan—Malaise—Formoterol—chronic obstructive pulmonary disease	0.000217	0.0018	CcSEcCtD
Frovatriptan—Hiccups—Prednisone—chronic obstructive pulmonary disease	0.000217	0.0018	CcSEcCtD
Frovatriptan—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000217	0.0018	CcSEcCtD
Frovatriptan—Osteoarthritis—Prednisolone—chronic obstructive pulmonary disease	0.000217	0.0018	CcSEcCtD
Frovatriptan—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000214	0.00178	CcSEcCtD
Frovatriptan—HTR1A—Monoamine GPCRs—ADRB2—chronic obstructive pulmonary disease	0.000214	0.0187	CbGpPWpGaD
Frovatriptan—Affect lability—Prednisolone—chronic obstructive pulmonary disease	0.000213	0.00177	CcSEcCtD
Frovatriptan—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000213	0.00177	CcSEcCtD
Frovatriptan—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000213	0.00176	CcSEcCtD
Frovatriptan—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000213	0.00176	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000211	0.00175	CcSEcCtD
Frovatriptan—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000211	0.00175	CcSEcCtD
Frovatriptan—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000209	0.00173	CcSEcCtD
Frovatriptan—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000209	0.00173	CcSEcCtD
Frovatriptan—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000208	0.00173	CcSEcCtD
Frovatriptan—Mood swings—Prednisolone—chronic obstructive pulmonary disease	0.000205	0.0017	CcSEcCtD
Frovatriptan—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000205	0.0017	CcSEcCtD
Frovatriptan—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000205	0.0017	CcSEcCtD
Frovatriptan—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000205	0.0017	CcSEcCtD
Frovatriptan—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000205	0.0017	CcSEcCtD
Frovatriptan—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000205	0.0017	CcSEcCtD
Frovatriptan—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000205	0.0017	CcSEcCtD
Frovatriptan—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000205	0.0017	CcSEcCtD
Frovatriptan—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000204	0.00169	CcSEcCtD
Frovatriptan—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000204	0.00169	CcSEcCtD
Frovatriptan—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000204	0.00169	CcSEcCtD
Frovatriptan—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000204	0.00169	CcSEcCtD
Frovatriptan—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000204	0.00169	CcSEcCtD
Frovatriptan—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000204	0.00169	CcSEcCtD
Frovatriptan—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000204	0.00169	CcSEcCtD
Frovatriptan—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000203	0.00168	CcSEcCtD
Frovatriptan—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000203	0.00168	CcSEcCtD
Frovatriptan—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000201	0.00167	CcSEcCtD
Frovatriptan—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000201	0.00167	CcSEcCtD
Frovatriptan—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000201	0.00167	CcSEcCtD
Frovatriptan—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000201	0.00166	CcSEcCtD
Frovatriptan—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000201	0.00166	CcSEcCtD
Frovatriptan—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.0002	0.00166	CcSEcCtD
Frovatriptan—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.0002	0.00166	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000199	0.00165	CcSEcCtD
Frovatriptan—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000197	0.00163	CcSEcCtD
Frovatriptan—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000197	0.00163	CcSEcCtD
Frovatriptan—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000194	0.00161	CcSEcCtD
Frovatriptan—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000194	0.00161	CcSEcCtD
Frovatriptan—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000194	0.00161	CcSEcCtD
Frovatriptan—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000193	0.0016	CcSEcCtD
Frovatriptan—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000193	0.0016	CcSEcCtD
Frovatriptan—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000193	0.0016	CcSEcCtD
Frovatriptan—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000192	0.00159	CcSEcCtD
Frovatriptan—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000192	0.00159	CcSEcCtD
Frovatriptan—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000191	0.00159	CcSEcCtD
Frovatriptan—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000191	0.00158	CcSEcCtD
Frovatriptan—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00019	0.00158	CcSEcCtD
Frovatriptan—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000189	0.00157	CcSEcCtD
Frovatriptan—HTR1D—Amine ligand-binding receptors—HTR2A—chronic obstructive pulmonary disease	0.000188	0.0164	CbGpPWpGaD
Frovatriptan—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000186	0.00154	CcSEcCtD
Frovatriptan—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000186	0.00154	CcSEcCtD
Frovatriptan—HTR1B—Amine ligand-binding receptors—HTR2A—chronic obstructive pulmonary disease	0.000184	0.0161	CbGpPWpGaD
Frovatriptan—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000183	0.00151	CcSEcCtD
Frovatriptan—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000183	0.00151	CcSEcCtD
Frovatriptan—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000182	0.00151	CcSEcCtD
Frovatriptan—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000181	0.0015	CcSEcCtD
Frovatriptan—HTR1A—Amine ligand-binding receptors—ADRB2—chronic obstructive pulmonary disease	0.00018	0.0157	CbGpPWpGaD
Frovatriptan—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00018	0.00149	CcSEcCtD
Frovatriptan—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00018	0.00149	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000179	0.00148	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000179	0.00148	CcSEcCtD
Frovatriptan—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000178	0.00147	CcSEcCtD
Frovatriptan—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000178	0.00147	CcSEcCtD
Frovatriptan—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000177	0.00147	CcSEcCtD
Frovatriptan—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000177	0.00147	CcSEcCtD
Frovatriptan—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000176	0.00146	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000175	0.00145	CcSEcCtD
Frovatriptan—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000175	0.00145	CcSEcCtD
Frovatriptan—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000175	0.00145	CcSEcCtD
Frovatriptan—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000175	0.00145	CcSEcCtD
Frovatriptan—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000175	0.00145	CcSEcCtD
Frovatriptan—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000174	0.00144	CcSEcCtD
Frovatriptan—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000173	0.00143	CcSEcCtD
Frovatriptan—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000173	0.00143	CcSEcCtD
Frovatriptan—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000173	0.00143	CcSEcCtD
Frovatriptan—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000172	0.00143	CcSEcCtD
Frovatriptan—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000171	0.00142	CcSEcCtD
Frovatriptan—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000171	0.00142	CcSEcCtD
Frovatriptan—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00017	0.00141	CcSEcCtD
Frovatriptan—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00017	0.00141	CcSEcCtD
Frovatriptan—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00017	0.00141	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000169	0.0014	CcSEcCtD
Frovatriptan—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000168	0.00139	CcSEcCtD
Frovatriptan—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000168	0.00139	CcSEcCtD
Frovatriptan—Pain—Formoterol—chronic obstructive pulmonary disease	0.000168	0.00139	CcSEcCtD
Frovatriptan—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000168	0.00139	CcSEcCtD
Frovatriptan—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000168	0.00139	CcSEcCtD
Frovatriptan—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000168	0.00139	CcSEcCtD
Frovatriptan—HTR1A—Monoamine GPCRs—HTR2A—chronic obstructive pulmonary disease	0.000167	0.0146	CbGpPWpGaD
Frovatriptan—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000167	0.00138	CcSEcCtD
Frovatriptan—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000166	0.00138	CcSEcCtD
Frovatriptan—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000166	0.00137	CcSEcCtD
Frovatriptan—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000165	0.00137	CcSEcCtD
Frovatriptan—Pain—Montelukast—chronic obstructive pulmonary disease	0.000165	0.00137	CcSEcCtD
Frovatriptan—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000165	0.00136	CcSEcCtD
Frovatriptan—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000164	0.00136	CcSEcCtD
Frovatriptan—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000164	0.00136	CcSEcCtD
Frovatriptan—CYP1A2—Estrogen Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.000164	0.0143	CbGpPWpGaD
Frovatriptan—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000163	0.00135	CcSEcCtD
Frovatriptan—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000163	0.00135	CcSEcCtD
Frovatriptan—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000162	0.00135	CcSEcCtD
Frovatriptan—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000162	0.00134	CcSEcCtD
Frovatriptan—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000162	0.00134	CcSEcCtD
Frovatriptan—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000162	0.00134	CcSEcCtD
Frovatriptan—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000161	0.00134	CcSEcCtD
Frovatriptan—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000161	0.00134	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000161	0.00133	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000161	0.00133	CcSEcCtD
Frovatriptan—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00016	0.00133	CcSEcCtD
Frovatriptan—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000159	0.00132	CcSEcCtD
Frovatriptan—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000159	0.00132	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000158	0.00131	CcSEcCtD
Frovatriptan—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000157	0.0013	CcSEcCtD
Frovatriptan—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000155	0.00129	CcSEcCtD
Frovatriptan—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000155	0.00129	CcSEcCtD
Frovatriptan—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000155	0.00129	CcSEcCtD
Frovatriptan—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000155	0.00129	CcSEcCtD
Frovatriptan—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000155	0.00128	CcSEcCtD
Frovatriptan—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000155	0.00128	CcSEcCtD
Frovatriptan—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000153	0.00127	CcSEcCtD
Frovatriptan—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000153	0.00127	CcSEcCtD
Frovatriptan—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000153	0.00127	CcSEcCtD
Frovatriptan—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000153	0.00126	CcSEcCtD
Frovatriptan—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000152	0.00126	CcSEcCtD
Frovatriptan—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000152	0.00126	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000152	0.00126	CcSEcCtD
Frovatriptan—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000151	0.00125	CcSEcCtD
Frovatriptan—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.00015	0.00124	CcSEcCtD
Frovatriptan—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000149	0.00124	CcSEcCtD
Frovatriptan—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000147	0.00122	CcSEcCtD
Frovatriptan—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000147	0.00122	CcSEcCtD
Frovatriptan—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000145	0.0012	CcSEcCtD
Frovatriptan—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000145	0.0012	CcSEcCtD
Frovatriptan—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000145	0.0012	CcSEcCtD
Frovatriptan—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000144	0.0012	CcSEcCtD
Frovatriptan—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000142	0.00118	CcSEcCtD
Frovatriptan—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000141	0.00117	CcSEcCtD
Frovatriptan—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000141	0.00117	CcSEcCtD
Frovatriptan—HTR1A—Amine ligand-binding receptors—HTR2A—chronic obstructive pulmonary disease	0.00014	0.0123	CbGpPWpGaD
Frovatriptan—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000139	0.00115	CcSEcCtD
Frovatriptan—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000139	0.00115	CcSEcCtD
Frovatriptan—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000139	0.00115	CcSEcCtD
Frovatriptan—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000139	0.0121	CbGpPWpGaD
Frovatriptan—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000138	0.00115	CcSEcCtD
Frovatriptan—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000137	0.00113	CcSEcCtD
Frovatriptan—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000136	0.00113	CcSEcCtD
Frovatriptan—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000135	0.00112	CcSEcCtD
Frovatriptan—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000135	0.00112	CcSEcCtD
Frovatriptan—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000134	0.00111	CcSEcCtD
Frovatriptan—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000133	0.0011	CcSEcCtD
Frovatriptan—CYP1A2—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000133	0.0116	CbGpPWpGaD
Frovatriptan—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000133	0.0011	CcSEcCtD
Frovatriptan—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000132	0.00109	CcSEcCtD
Frovatriptan—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000131	0.00109	CcSEcCtD
Frovatriptan—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00013	0.00108	CcSEcCtD
Frovatriptan—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00013	0.00108	CcSEcCtD
Frovatriptan—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000127	0.00106	CcSEcCtD
Frovatriptan—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000127	0.00105	CcSEcCtD
Frovatriptan—CYP1A2—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000126	0.011	CbGpPWpGaD
Frovatriptan—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000125	0.00104	CcSEcCtD
Frovatriptan—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000125	0.00104	CcSEcCtD
Frovatriptan—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000123	0.00102	CcSEcCtD
Frovatriptan—Headache—Formoterol—chronic obstructive pulmonary disease	0.000123	0.00102	CcSEcCtD
Frovatriptan—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000123	0.00102	CcSEcCtD
Frovatriptan—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000122	0.00101	CcSEcCtD
Frovatriptan—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000121	0.001	CcSEcCtD
Frovatriptan—Depression—Prednisone—chronic obstructive pulmonary disease	0.000121	0.001	CcSEcCtD
Frovatriptan—Headache—Montelukast—chronic obstructive pulmonary disease	0.000121	0.001	CcSEcCtD
Frovatriptan—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.00012	0.000991	CcSEcCtD
Frovatriptan—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000119	0.000986	CcSEcCtD
Frovatriptan—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000118	0.000978	CcSEcCtD
Frovatriptan—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000118	0.000975	CcSEcCtD
Frovatriptan—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000117	0.000972	CcSEcCtD
Frovatriptan—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000117	0.00097	CcSEcCtD
Frovatriptan—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000117	0.000968	CcSEcCtD
Frovatriptan—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000117	0.000968	CcSEcCtD
Frovatriptan—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000116	0.000964	CcSEcCtD
Frovatriptan—CYP1A2—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000116	0.0101	CbGpPWpGaD
Frovatriptan—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000115	0.00095	CcSEcCtD
Frovatriptan—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000114	0.000948	CcSEcCtD
Frovatriptan—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000113	0.000937	CcSEcCtD
Frovatriptan—CYP1A2—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000111	0.00973	CbGpPWpGaD
Frovatriptan—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000111	0.000919	CcSEcCtD
Frovatriptan—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00011	0.000914	CcSEcCtD
Frovatriptan—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.00011	0.00091	CcSEcCtD
Frovatriptan—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000109	0.000907	CcSEcCtD
Frovatriptan—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000109	0.000903	CcSEcCtD
Frovatriptan—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000106	0.000883	CcSEcCtD
Frovatriptan—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000105	0.000868	CcSEcCtD
Frovatriptan—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000104	0.000861	CcSEcCtD
Frovatriptan—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000103	0.000853	CcSEcCtD
Frovatriptan—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000101	0.000838	CcSEcCtD
Frovatriptan—CYP1A2—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	9.74e-05	0.00851	CbGpPWpGaD
Frovatriptan—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	9.73e-05	0.000806	CcSEcCtD
Frovatriptan—Insomnia—Prednisolone—chronic obstructive pulmonary disease	9.63e-05	0.000798	CcSEcCtD
Frovatriptan—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	9.56e-05	0.000793	CcSEcCtD
Frovatriptan—Mental disorder—Prednisone—chronic obstructive pulmonary disease	9.54e-05	0.000791	CcSEcCtD
Frovatriptan—HTR1D—G alpha (i) signalling events—CXCR2—chronic obstructive pulmonary disease	9.5e-05	0.00829	CbGpPWpGaD
Frovatriptan—Malnutrition—Prednisone—chronic obstructive pulmonary disease	9.48e-05	0.000786	CcSEcCtD
Frovatriptan—HTR1B—G alpha (i) signalling events—CXCR2—chronic obstructive pulmonary disease	9.3e-05	0.00812	CbGpPWpGaD
Frovatriptan—CYP1A2—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	9.19e-05	0.00802	CbGpPWpGaD
Frovatriptan—Pain—Prednisolone—chronic obstructive pulmonary disease	9.11e-05	0.000755	CcSEcCtD
Frovatriptan—HTR1D—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	8.81e-05	0.00769	CbGpPWpGaD
Frovatriptan—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	8.8e-05	0.000729	CcSEcCtD
Frovatriptan—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	8.78e-05	0.000727	CcSEcCtD
Frovatriptan—Agitation—Prednisone—chronic obstructive pulmonary disease	8.71e-05	0.000722	CcSEcCtD
Frovatriptan—HTR1A—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	8.71e-05	0.0076	CbGpPWpGaD
Frovatriptan—HTR1B—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	8.63e-05	0.00753	CbGpPWpGaD
Frovatriptan—CYP1A2—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	8.61e-05	0.00752	CbGpPWpGaD
Frovatriptan—Malaise—Prednisone—chronic obstructive pulmonary disease	8.55e-05	0.000709	CcSEcCtD
Frovatriptan—Vertigo—Prednisone—chronic obstructive pulmonary disease	8.52e-05	0.000706	CcSEcCtD
Frovatriptan—Syncope—Prednisone—chronic obstructive pulmonary disease	8.5e-05	0.000705	CcSEcCtD
Frovatriptan—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	8.33e-05	0.000691	CcSEcCtD
Frovatriptan—Convulsion—Prednisone—chronic obstructive pulmonary disease	8.22e-05	0.000681	CcSEcCtD
Frovatriptan—Arthralgia—Prednisone—chronic obstructive pulmonary disease	8.07e-05	0.000669	CcSEcCtD
Frovatriptan—Myalgia—Prednisone—chronic obstructive pulmonary disease	8.07e-05	0.000669	CcSEcCtD
Frovatriptan—Anxiety—Prednisone—chronic obstructive pulmonary disease	8.04e-05	0.000667	CcSEcCtD
Frovatriptan—Discomfort—Prednisone—chronic obstructive pulmonary disease	7.98e-05	0.000661	CcSEcCtD
Frovatriptan—HTR1A—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	7.86e-05	0.00686	CbGpPWpGaD
Frovatriptan—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	7.85e-05	0.00065	CcSEcCtD
Frovatriptan—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	7.74e-05	0.000641	CcSEcCtD
Frovatriptan—Shock—Prednisone—chronic obstructive pulmonary disease	7.61e-05	0.000631	CcSEcCtD
Frovatriptan—Tachycardia—Prednisone—chronic obstructive pulmonary disease	7.55e-05	0.000626	CcSEcCtD
Frovatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	7.55e-05	0.00659	CbGpPWpGaD
Frovatriptan—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	7.48e-05	0.00062	CcSEcCtD
Frovatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	7.39e-05	0.00645	CbGpPWpGaD
Frovatriptan—Anorexia—Prednisone—chronic obstructive pulmonary disease	7.38e-05	0.000611	CcSEcCtD
Frovatriptan—HTR1A—G alpha (i) signalling events—CXCR2—chronic obstructive pulmonary disease	7.08e-05	0.00618	CbGpPWpGaD
Frovatriptan—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	7.05e-05	0.000584	CcSEcCtD
Frovatriptan—Dizziness—Prednisolone—chronic obstructive pulmonary disease	7.04e-05	0.000584	CcSEcCtD
Frovatriptan—Insomnia—Prednisone—chronic obstructive pulmonary disease	7e-05	0.00058	CcSEcCtD
Frovatriptan—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	6.95e-05	0.000576	CcSEcCtD
Frovatriptan—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	6.81e-05	0.000565	CcSEcCtD
Frovatriptan—CYP1A2—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	6.77e-05	0.00591	CbGpPWpGaD
Frovatriptan—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	6.73e-05	0.000558	CcSEcCtD
Frovatriptan—Fatigue—Prednisone—chronic obstructive pulmonary disease	6.67e-05	0.000553	CcSEcCtD
Frovatriptan—Headache—Prednisolone—chronic obstructive pulmonary disease	6.67e-05	0.000553	CcSEcCtD
Frovatriptan—Constipation—Prednisone—chronic obstructive pulmonary disease	6.62e-05	0.000548	CcSEcCtD
Frovatriptan—HTR1A—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	6.57e-05	0.00574	CbGpPWpGaD
Frovatriptan—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	6.38e-05	0.000529	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	6.33e-05	0.000524	CcSEcCtD
Frovatriptan—Nausea—Prednisolone—chronic obstructive pulmonary disease	6.33e-05	0.000524	CcSEcCtD
Frovatriptan—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	6.12e-05	0.000507	CcSEcCtD
Frovatriptan—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	6.12e-05	0.000507	CcSEcCtD
Frovatriptan—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	5.95e-05	0.0052	CbGpPWpGaD
Frovatriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	5.95e-05	0.0052	CbGpPWpGaD
Frovatriptan—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	5.95e-05	0.0052	CbGpPWpGaD
Frovatriptan—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	5.87e-05	0.00512	CbGpPWpGaD
Frovatriptan—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	5.8e-05	0.00506	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	5.75e-05	0.00502	CbGpPWpGaD
Frovatriptan—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	5.7e-05	0.000473	CcSEcCtD
Frovatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	5.63e-05	0.00492	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	5.63e-05	0.00491	CbGpPWpGaD
Frovatriptan—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	5.57e-05	0.00486	CbGpPWpGaD
Frovatriptan—Asthenia—Prednisone—chronic obstructive pulmonary disease	5.55e-05	0.00046	CcSEcCtD
Frovatriptan—HTR1D—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	5.53e-05	0.00483	CbGpPWpGaD
Frovatriptan—Pruritus—Prednisone—chronic obstructive pulmonary disease	5.48e-05	0.000454	CcSEcCtD
Frovatriptan—HTR1A—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	5.45e-05	0.00476	CbGpPWpGaD
Frovatriptan—HTR1B—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	5.41e-05	0.00473	CbGpPWpGaD
Frovatriptan—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	5.3e-05	0.000439	CcSEcCtD
Frovatriptan—Dizziness—Prednisone—chronic obstructive pulmonary disease	5.12e-05	0.000424	CcSEcCtD
Frovatriptan—Vomiting—Prednisone—chronic obstructive pulmonary disease	4.92e-05	0.000408	CcSEcCtD
Frovatriptan—Headache—Prednisone—chronic obstructive pulmonary disease	4.85e-05	0.000402	CcSEcCtD
Frovatriptan—HTR1A—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	4.82e-05	0.00421	CbGpPWpGaD
Frovatriptan—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	4.81e-05	0.0042	CbGpPWpGaD
Frovatriptan—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	4.75e-05	0.00415	CbGpPWpGaD
Frovatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	4.74e-05	0.00413	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	4.71e-05	0.00411	CbGpPWpGaD
Frovatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	4.64e-05	0.00405	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	4.61e-05	0.00403	CbGpPWpGaD
Frovatriptan—Nausea—Prednisone—chronic obstructive pulmonary disease	4.6e-05	0.000381	CcSEcCtD
Frovatriptan—HTR1D—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	4.32e-05	0.00377	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	4.29e-05	0.00374	CbGpPWpGaD
Frovatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	4.23e-05	0.0037	CbGpPWpGaD
Frovatriptan—HTR1B—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	4.23e-05	0.00369	CbGpPWpGaD
Frovatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	4.14e-05	0.00362	CbGpPWpGaD
Frovatriptan—HTR1A—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	4.12e-05	0.0036	CbGpPWpGaD
Frovatriptan—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	4.07e-05	0.00355	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	4.03e-05	0.00352	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	3.95e-05	0.00345	CbGpPWpGaD
Frovatriptan—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	3.9e-05	0.00341	CbGpPWpGaD
Frovatriptan—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	3.74e-05	0.00326	CbGpPWpGaD
Frovatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	3.7e-05	0.00323	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	3.66e-05	0.0032	CbGpPWpGaD
Frovatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	3.63e-05	0.00317	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	3.61e-05	0.00315	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	3.58e-05	0.00313	CbGpPWpGaD
Frovatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	3.53e-05	0.00308	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	3.53e-05	0.00308	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	3.51e-05	0.00307	CbGpPWpGaD
Frovatriptan—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	3.43e-05	0.003	CbGpPWpGaD
Frovatriptan—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	3.39e-05	0.00296	CbGpPWpGaD
Frovatriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	3.29e-05	0.00287	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	3.25e-05	0.00284	CbGpPWpGaD
Frovatriptan—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	3.22e-05	0.00281	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	3.22e-05	0.00281	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	3.18e-05	0.00278	CbGpPWpGaD
Frovatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	3.16e-05	0.00276	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	3.16e-05	0.00276	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	3.01e-05	0.00262	CbGpPWpGaD
Frovatriptan—HTR1A—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	2.98e-05	0.0026	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	2.95e-05	0.00258	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	2.89e-05	0.00252	CbGpPWpGaD
Frovatriptan—HTR1D—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	2.88e-05	0.00251	CbGpPWpGaD
Frovatriptan—HTR1A—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	2.86e-05	0.00249	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	2.85e-05	0.00249	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	2.82e-05	0.00246	CbGpPWpGaD
Frovatriptan—HTR1B—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	2.82e-05	0.00246	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	2.79e-05	0.00244	CbGpPWpGaD
Frovatriptan—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	2.79e-05	0.00243	CbGpPWpGaD
Frovatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	2.76e-05	0.00241	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	2.76e-05	0.00241	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	2.73e-05	0.00238	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	2.69e-05	0.00235	CbGpPWpGaD
Frovatriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	2.56e-05	0.00223	CbGpPWpGaD
Frovatriptan—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	2.51e-05	0.00219	CbGpPWpGaD
Frovatriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	2.51e-05	0.00219	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	2.42e-05	0.00212	CbGpPWpGaD
Frovatriptan—HTR1A—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	2.42e-05	0.00211	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	2.41e-05	0.00211	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	2.4e-05	0.0021	CbGpPWpGaD
Frovatriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	2.39e-05	0.00209	CbGpPWpGaD
Frovatriptan—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	2.39e-05	0.00209	CbGpPWpGaD
Frovatriptan—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.38e-05	0.00208	CbGpPWpGaD
Frovatriptan—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.35e-05	0.00205	CbGpPWpGaD
Frovatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	2.29e-05	0.002	CbGpPWpGaD
Frovatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	2.24e-05	0.00196	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	2.2e-05	0.00192	CbGpPWpGaD
Frovatriptan—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.19e-05	0.00191	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.16e-05	0.00189	CbGpPWpGaD
Frovatriptan—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.16e-05	0.00188	CbGpPWpGaD
Frovatriptan—HTR1A—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	2.15e-05	0.00187	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	2.13e-05	0.00186	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.12e-05	0.00185	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	2.1e-05	0.00184	CbGpPWpGaD
Frovatriptan—HTR1A—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	2.07e-05	0.00181	CbGpPWpGaD
Frovatriptan—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.07e-05	0.00181	CbGpPWpGaD
Frovatriptan—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.04e-05	0.00178	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	2.04e-05	0.00178	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	2e-05	0.00174	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.85e-05	0.00162	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.82e-05	0.00159	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.81e-05	0.00158	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.78e-05	0.00156	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.74e-05	0.00152	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.74e-05	0.00152	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.71e-05	0.00149	CbGpPWpGaD
Frovatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	1.71e-05	0.00149	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.71e-05	0.00149	CbGpPWpGaD
Frovatriptan—HTR1A—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	1.67e-05	0.00146	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	1.67e-05	0.00146	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.65e-05	0.00144	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.62e-05	0.00141	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.61e-05	0.00141	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.59e-05	0.00139	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.56e-05	0.00136	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.52e-05	0.00133	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.45e-05	0.00126	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.42e-05	0.00124	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.38e-05	0.00121	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.36e-05	0.00119	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.3e-05	0.00114	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.3e-05	0.00113	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.27e-05	0.00111	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.25e-05	0.00109	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.23e-05	0.00108	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.19e-05	0.00104	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.19e-05	0.00104	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.18e-05	0.00103	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.16e-05	0.00101	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.1e-05	0.000964	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.09e-05	0.000955	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.08e-05	0.000942	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.07e-05	0.000938	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.07e-05	0.000935	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	9.99e-06	0.000872	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	9.84e-06	0.000859	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	9.77e-06	0.000853	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	9.64e-06	0.000841	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	9.57e-06	0.000835	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	9.51e-06	0.00083	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	8.94e-06	0.00078	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.88e-06	0.000775	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—KL—chronic obstructive pulmonary disease	8.84e-06	0.000772	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	8.75e-06	0.000764	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.7e-06	0.000759	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	8.55e-06	0.000746	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	8.37e-06	0.000731	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	8.16e-06	0.000712	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	7.96e-06	0.000695	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.95e-06	0.000694	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.78e-06	0.000679	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	7.34e-06	0.000641	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	7.29e-06	0.000636	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	6.67e-06	0.000582	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.62e-06	0.000578	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.53e-06	0.00057	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.4e-06	0.000559	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.38e-06	0.000557	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.24e-06	0.000544	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.11e-06	0.000533	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.95e-06	0.00052	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.93e-06	0.000517	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.87e-06	0.000512	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.83e-06	0.000509	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	5.8e-06	0.000506	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	5.41e-06	0.000472	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	5.29e-06	0.000462	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.28e-06	0.000461	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.17e-06	0.000451	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.02e-06	0.000438	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.92e-06	0.000429	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.87e-06	0.000425	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.78e-06	0.000417	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.68e-06	0.000408	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.65e-06	0.000406	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.44e-06	0.000388	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.29e-06	0.000374	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.2e-06	0.000367	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.07e-06	0.000355	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.01e-06	0.00035	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.94e-06	0.000344	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.94e-06	0.000344	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.86e-06	0.000337	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.85e-06	0.000337	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.78e-06	0.00033	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.75e-06	0.000327	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.74e-06	0.000326	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.56e-06	0.000311	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.54e-06	0.000309	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.24e-06	0.000283	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.2e-06	0.000279	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.17e-06	0.000277	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.97e-06	0.000259	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.94e-06	0.000256	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.9e-06	0.000254	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.88e-06	0.000251	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.42e-06	0.000211	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	2.41e-06	0.00021	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	2.3e-06	0.000201	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.21e-06	0.000193	CbGpPWpGaD
